Randomized phase II study of cisplatin/vinorelbine vs cisplatin/gemcitabine vs vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Tsai, CM [1 ]
Perng, RP [1 ]
Wang, GS [1 ]
Chen, YM [1 ]
机构：
[1] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [31] Sequential chemotherapy with paclitaxel, cisplatin, Gemcitabine and vinorelbine in advanced non-small-cell lung cancer:: A phase II study.
    Barón, MG
    Ordóñez, A
    Martin, G
    Dorta, J
    Murias, A
    Madroñal, C
    Feliu, J
    Lizón, J
    Aguiar, J
    Vázquez, Y
    ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
  • [32] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
    Hasturk, Serap
    Hatabay, Nilgun
    Ece, Ferah
    Karatasli, Meltem
    Hanta, Ismail
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285
  • [33] Gemcitabine (GEM) Cisplatin (CDDP) Vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study
    Comella, P
    Panza, N
    Frasci, G
    Pacillo, C
    Nicolella, GP
    Natale, M
    DeCataldis, G
    Manzione, L
    Bilancia, D
    Cioffi, R
    Micillo, E
    Maiorino, L
    Lorusso, V
    Ianniello, GP
    DellaVittoria, M
    Piantedosi, F
    Perchard, J
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1037 - 1037
  • [34] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [35] A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer
    Hotta, K
    Sekine, I
    Tamura, T
    Sawada, M
    Watanabe, H
    Kusaba, H
    Akiyama, Y
    Inoue, A
    Shimoyama, T
    Nokihara, H
    Ueda, Y
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 596 - 600
  • [36] Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naive non-small cell lung cancer
    Keskin, Serkan
    Tas, Faruk
    Ekenel, Meltem
    Kilic, Leyla
    Sen, Fatma
    Yildiz, Ibrahim
    Karabulut, Senem
    Ciftci, Rumeysa
    Vatansever, Sezai
    TUMORI, 2013, 99 (04) : 463 - 468
  • [37] Gemcitabine-cisplatin-vinorelbine phase II trial in stage III non small cell lung cancer
    Cueva, JF
    Grande, C
    Firvida, J
    Amenedo, M
    Lázaro, M
    Romero, C
    Quintero, G
    Huidobro, G
    García, J
    Barón, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S259 - S259
  • [38] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [39] Gemcitabine/vinorelbine followed by paclitaxel versus cisplatin/gemcitabine/vinorelbine versus cisplatin/paclitaxel in advanced non-small cell lung cancer: final results of the AASLC-AIO-3 phase III trial
    Pirker, Robert
    Fischer, Berthold
    Eberhardt, Wilfried
    Niederle, Norbert
    Mohn-Staudner, Andrea
    Ewert, Ralf
    Benisch, Peter
    Pfeifer, Wolfgang
    Gauler, Thomas
    Griesinger, Frank
    Minar, Wilma
    Buhl, Roland
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S286 - S286
  • [40] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
12345